Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / March / Ophthalmology's Role in the Opioid Crisis
Health Economics and Policy Interview Research & Innovations

Ophthalmology’s Role in the Opioid Crisis

Retrospective cohort study investigates how ophthalmologists can provide potentially life-saving care to substance use disorder patients

By Alun Evans 3/19/2026 3 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions
  • Top Thought Leaders

Clinical Report: Ophthalmology’s Role in the Opioid Crisis

Overview

Ophthalmologists are positioned to intervene in the opioid crisis by identifying and treating patients with injection drug use-associated endogenous endophthalmitis (IDU-EE) and facilitating access to addiction care. The study highlights the need for integrated addiction care during hospitalization to improve patient outcomes.

Background

The opioid crisis remains a significant public health issue in the United States, with opioids being a leading cause of overdose deaths, accounting for over 70% of all drug overdose deaths in recent years. Ophthalmologists encounter patients with substance use disorders, particularly those presenting with IDU-EE, providing a unique opportunity for early intervention. Addressing substance abuse in this context can potentially reduce both vision loss and the risk of overdose.

Data Highlights

The study analyzed data from Mass General Brigham over a six-year period, focusing on visual outcomes such as visual acuity and the need for surgical intervention, as well as addiction care for patients with IDU-EE.

Key Findings

  • Fentanyl use was associated with worse visual outcomes in patients with IDU-EE, indicating a need for targeted interventions.
  • Diagnosis of IDU-EE requires a combination of slit lamp and indirect ophthalmoscopy techniques, which may not be readily available in all settings.
  • No opioid use disorder medication was administered unless addiction consult services were involved, highlighting a gap in care.
  • Hospitalization presents a critical opportunity to connect patients with evidence-based addiction treatments, which can significantly improve long-term outcomes.
  • Ophthalmologists can play a role in normalizing and triggering addiction consult involvement, which is essential for comprehensive patient care.

Clinical Implications

Ophthalmologists should be vigilant in identifying signs of substance use disorders, such as changes in behavior or physical signs, in patients presenting with acute vision loss. Integrating addiction consultation services during hospitalization can enhance patient care and reduce the risk of future substance-related complications.

Conclusion

The findings underscore the importance of ophthalmologists in addressing the opioid crisis through early intervention and collaboration with addiction specialists. Enhanced care pathways, including routine addiction consults, can lead to improved outcomes for patients with substance use disorders.

References

  1. CDC, About Overdose Prevention, 2023 -- Overview of opioid overdose prevention efforts
  2. CDC, Initiating Opioid Therapy, 2023 -- Guidelines for opioid prescribing
  3. ADA News, Opioid epidemic reaches crescendo as COVID-19 stays center stage, 2021 -- Overview of opioid crisis statistics
  4. Optometric Management, CONQUERING OPIOID ADDICTION, 2019 -- Personal journey of recovery from opioid addiction
  5. Ophthalmic Professional, COMPLIANCE, 2024 -- New DEA requirements for opioid management
  6. ADA News — Webinar: Dentists can play a role in blunting opioid epidemic
  7. About Overdose Prevention | Overdose Prevention | CDC
  8. Initiating Opioid Therapy | Overdose Prevention | CDC
  9. NSAIDs and Corticosteroids for the Postoperative Management of Age-Related Cataract Surgery: A Systematic Review and Meta-analysis - ScienceDirect

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: